Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

Search

Top

MAXIM BIOMEDICAL, INC

UEI: YV7LJS28ERK8CAGE: 4EJW3

MAXIM BIOMEDICAL, INC is a federal contractor, registered under UEI YV7LJS28ERK8 and CAGE code 4EJW3. It has been awarded $128,723,256 in federal contracts. Primary work spans In-Vitro Diagnostic Substance Manufacturing, Unknown NAICS, and Medical Laboratories. Top awarding agencies include Department Of Health And Human Services, Department Of Defense, and Department Of Health And Human Services (hhs).

Contact Information

Registration and classification details

Emailcontact@company.com

Phone+1 (555) 000-0000

Websitehttp://www.maximbio.com

Address123 Main St, City, ST 12345

Registration

UEI Code

YV7LJS28ERK8

CAGE Code

4EJW3

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit OrganizationAsian-Pacific American OwnedManufacturer of Goods

NAICS Codes

325413In-Vitro Diagnostic Substance Manufacturing(Primary)

325414Biological Product (except Diagnostic) Manufacturing

334516Analytical Laboratory Instrument Manufacturing

334519Other Measuring and Controlling Device Manufacturing

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

MAXIM BIOMEDICAL, INC specializes in the manufacturing of in-vitro diagnostic substances and operates within the medical laboratory services domain, delivering critical public health solutions under federal contracts. The company’s core capabilities center on the development, production, and regulat...

Key Performance Metrics

Awards Count

30

All time

Active

1

Currently performing

Completed

29

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

Department Of Health And Human Services$57.8M44.9%Department Of Defense$55.2M42.9%Department Of Health And Human Services (hhs)$15.5M12%

Other agencies (2 agencies, <0.5% each)$232.8K0.2%

Awards by NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing$107.3M83.4%

- Unknown NAICS$15.5M12%

621511 - Medical Laboratories$5.3M4.1%

Others - Other NAICS codes (3 codes, <0.5% each)$689.6K0.5%

Awards by Agency Over Time

Awards by Place of Performance

Compete with MAXIM BIOMEDICAL, INC

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for MAXIM BIOMEDICAL, INC

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Join 750+ contractors already using CLEATUS

Open opportunities in MAXIM BIOMEDICAL, INC's top NAICS codes and agencies

Confirmatory Drug Testing Services (GC/MS)This subcontract involves providing high-complexity confirmatory drug testing services for prime contractors working on projects for the Department of Judiciary in the State of Hawaii. The selected provider must utilize Gas Chromatography/Mass Spectrometry (GC/MS) to analyze samples that have triggered positive initial screens, ensuring that all certified confirmatory test reports are delivered within 72 hours of sample submission. To be eligible, the laboratory must be licensed and accredited within the State of Hawaii and fully equipped with the necessary GC/MS instrumentation. This opportunity falls under NAICS code 621511, with a response deadline set for November 23, 2026.

Department of Judiciary

POSTED

about 17 hours ago

DEADLINE

Initial Drug Screening Services (EMIT/Equivalent)This subcontract involves providing initial drug screening services for prime contractors working on projects for the Department of Judiciary in the State of Hawaii. The selected provider must utilize the EMIT system or an approved equivalent to execute Screening Panels I and II, which cover substances including amphetamines, cocaine, cannabinoids, opiates, alcohol, and fentanyl. All initial screening test results must be delivered within 72 hours of sample submission. To qualify, the provider must operate a laboratory equipped for rapid screening that maintains appropriate accreditation. This opportunity falls under NAICS code 621511 and has a response deadline of November 23, 2026.

Department of Judiciary

POSTED

about 17 hours ago

DEADLINE

Urine Specimen Collection ServicesThis subcontract for Urine Specimen Collection Services supports prime contractors on Department of Judiciary projects throughout the State of Hawaii. The selected subcontractor is responsible for the physical collection and secure delivery of urine specimens, operating seven days a week at designated facilities. To ensure the integrity of the process, the provider must adhere to strict, Judiciary-approved written procedures designed to prevent tampering. Eligible providers must maintain a physical collection facility located within the O‘ahu, Maui, Hawai‘i, or Kaua‘i circuits. This opportunity falls under NAICS code 621511, with a response deadline set for November 23, 2026.

Department of Judiciary

POSTED

about 17 hours ago

DEADLINE

Statewide Sample Collection, Drug Screen & Confirmatory Testing

Solicitation # J28030

The Department of Judiciary for the State of Hawaii is soliciting bids under solicitation J28030 for statewide sample collection, initial drug screening, and confirmation testing. The contractor is responsible for collecting urine specimens from individuals referred by the First, Second, Third, and Fifth Circuit courts at their own or an approved subcontractor's facilities. Initial screenings must utilize the EMIT system or an approved equivalent, while confirmation testing must be performed using gas chromatography/mass spectrometry by a company licensed and accredited in Hawaii. The contractor must provide these services seven days a week and submit written procedures to the Officer-in-Charge to ensure samples are not tampered with during collection. The contract is for an initial twenty-four month term from July 1, 2027, through June 30, 2029, with the possibility of two additional twelve-month extensions. Award will be granted to the lowest responsive and responsible bidder, with preferences considered for Hawaii-based products and other statutory categories. Payment is based on the actual number of samples collected per month at the unit bid cost, with invoices submitted separately for each circuit. The contractor must maintain compliance with various Hawaii state laws, including tax clearances, unemployment insurance, and prepaid health care requirements.

Department of Judiciary

POSTED

about 17 hours ago

DEADLINE

TEST KIT, CORONAVIRUS D

Solicitation # SPE2DS-27-T-1071

Solicitation SPE2DS-27-T-1071, issued by the DLA Troop Support Medical Supply Chain, is for the procurement of one case of Abbott BinaxNOW COVID-19 Antigen self-test kits for over-the-counter, at-home use. Each case contains 12 kits with 2 tests per kit. The items must be stored between 2-30 degrees Celsius and have a non-extendable shelf life of 12 months, with no more than one month elapsed from the date of manufacture to the date of delivery. Delivery is required within 20 days after receipt of the order, with a final delivery date of October 30, 2026, to the USS IDAHO (SSN 799). The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and requires labels to include the contract or lot number and the date of manufacture, expiration, or retest. Packaging must be commercial, utilizing sealed unit containers and suitable exterior shipping containers. Inspection and acceptance will occur at the destination per FAR 52.246-2. Administrative requirements include the use of the Wide Area Workflow system for electronic invoicing and compliance with various FAR and DFARS clauses regarding cybersecurity, the Buy American Act, and the prohibition of covered defense telecommunications equipment. Quotations are due by November 3, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 22 hours ago

DEADLINE

CULTURE MEDIUM, THAYER-

Solicitation # SPE2DS-27-T-1066

Solicitation SPE2DS-27-T-1066 is a request for quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of one package of Thayer-Martin Modified (MTM II) Agar culture medium, identified by NSN 6550-01-711-1542. This dark brown, ready-to-use plated medium is specifically designed for the isolation of pathogenic Neisseria from specimens containing mixed flora of bacteria and fungi. The product is delivered in packages of 100 plates and requires strict refrigeration storage between 2 to 8 degrees Celsius (36 to 46 degrees Fahrenheit) and must not be frozen. The contract mandates a non-extendable shelf life of three months, with a requirement that no more than 14 days elapse between the date of manufacture and the date of delivery to the government. Delivery is set for JBER, Alaska, with a required delivery date of October 27, 2026, under FOB Destination terms. Packaging must be commercial and sealed to prevent damage, with marking adhering to Medical Marking Standard No. 1 and shelf-life labels following MMS1C. Administrative requirements include electronic invoicing via the Wide Area WorkFlow system and compliance with various FAR and DFARS clauses, including the Buy American Act, Berry Amendment, and safeguarding of covered defense information. Evaluation will consider technical data for any alternate products offered and may include HUBZone price evaluation preferences. Inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 22 hours ago

DEADLINE

U.S. Army Long Range Precision Munition Launched Effects Medium Range-Lethal Prototype Integration and Qualification

Solicitation # 11e09f87-099d-4282-abc4-f6a4ce589397

Department Of Defense

POSTED

about 22 hours ago

DEADLINE

Clinical STI Screening and Treatment ServicesThe Clinical STI Screening and Treatment Services subcontract involves providing clinical screening, diagnosis, and medical management of sexually transmitted infections for prime contractors working on East Riding of Yorkshire Council sexual health projects. The scope of work specifically emphasizes Chlamydia screening for females aged 15 to 24 and the early detection of HIV to minimize late-stage presentations. These services are delivered using clinical diagnostic tools and medical examination facilities to ensure patients are accurately diagnosed and treated. The contract is aligned with the Public Health Outcomes Framework indicators, with a primary focus on delivering treated patients and reporting detection rates. Interested parties must respond by November 23, 2026, for this initiative managed by the East Riding of Yorkshire Council under NAICS code 621511.

East Riding of Yorkshire Council

POSTED

about 23 hours ago

DEADLINE

RRC Drug and Alcohol Testing Laboratory ServicesThis subcontract for Residential Reentry Center projects under the Department of Justice involves providing specialized drug and alcohol testing laboratory services for prime contractors. The selected provider will be responsible for the collection and analysis of urine samples to detect narcotics and alcohol, ensuring the delivery of accurate test results and comprehensive reporting. The service provider must maintain strict adherence to regulatory standards, specifically 42 CFR Part 493 (CLIA), P.S. 6060, and P.S. 6590. Performance for this contract is centered in Springfield, falling under NAICS code 621511. Responses are due by November 12, 2026.

Residential Reentry - Co

POSTED

DEADLINE

Substance Abuse Testing and SurveillanceThis subcontract, titled Substance Abuse Testing and Surveillance, is issued by the Department of Justice for Residential Reentry projects. The selected provider will perform random drug and alcohol testing for prime contractors, utilizing urine surveillance, narcotic identification, and breathalyzer equipment. All activities, including testing intervals at facilities and during home visits, must be conducted in strict accordance with BOP P.S. 6060 and P.S. 6590 guidelines to ensure the delivery of verified results and compliance reports. The opportunity is categorized under NAICS code 621511 and was posted on October 28, 2026. Interested parties must submit their responses by the deadline of November 27, 2026.

Residential Reentry - Co

POSTED

DEADLINE

Supply of ALBAcyte Blood Bank ReagentsThis subcontract involves the manufacture and supply of specialized ALBAcyte blood bank reagents for prime contractors supporting the Department of Veterans Affairs North Texas Health Care System. The scope of work includes the delivery of A1, A2, B, IgG Sensitized, Antibody ID Panels, and C3 Coated RBCs. To ensure product efficacy, the contractor must utilize shipping containers that maintain reagent integrity and adhere to a defined Quality Plan and FDA approval standards. Deliveries are to be made FOB Destination to the Transfusion Medicine Unit located in Dallas, Texas. The contract is categorized under NAICS code 325413 and is managed through the Department of Veterans Affairs Network Contract Office 17.

257-NETWORK Contract Office 17 (36C257)

POSTED

DEADLINE

6550--Blood Bank Reagents

Solicitation # 36C25727Q0065

The Department of Veterans Affairs VA North Texas Health Care System is issuing a Sources Sought Notice to identify qualified vendors capable of providing blood bank reagents for the Transfusion Medicine Unit in Dallas, Texas. These reagents, including ALBAcyte A1, A2, B, IgG Sensitized, Antibody ID Panels, and C3 Coated Red Blood Cells, are essential for manual blood typing and serum antibody detection used in cross-matching blood for transfusions. The anticipated acquisition strategy includes a base year starting May 1, 2027, with four subsequent one-year option periods extending through April 30, 2032. To be considered, vendors must be FDA approved, provide documentation of such approval, and maintain a defined quality plan with adequate supply availability. All shipments must be FOB Destination, and the contractor is responsible for providing appropriate shipping containers. Interested vendors must submit an electronic capability statement in PDF or Word format, including the place of manufacture for all listed reagents, to the designated contract specialist by November 5, 2026, at 9:00 AM CST. This notice is for market research purposes only to determine the appropriate acquisition strategy, such as a small business set-aside, and does not constitute a formal solicitation.

257-NETWORK Contract Office 17 (36C257)

POSTED

DEADLINE

6505--DRESSING, DRAWTEX 4IN X 4IN (VA-27-00014447)

Solicitation # 36C77027Q0015

The Department of Veterans Affairs, National CMOP Office, is conducting market research through a Sources Sought announcement to identify qualified sources for the procurement of Drawtex Dressing, 4in X 4in, packaged as 10ct per box. This action is for market research purposes only and is not a formal solicitation for quotes; therefore, no contract will be awarded based on this specific announcement. The place of performance is located in Ladson, South Carolina, and the primary point of contact is Contract Specialist Claudine Challinor. Interested respondents must submit their information via email by November 3, 2026. Required details include the company's SAM Unique ID Number, business size (Small, Large, SDVOSB, or VOSB), and point of contact information. Specifically, the government is seeking to determine if the respondent is the manufacturer, the manufacturer's product number, and the place of manufacturing. If the respondent is not the manufacturer, they must provide a letter of authorization from the original equipment manufacturer or provide detailed product literature and specifications for alternative products that demonstrate similarities to the Drawtex hydro conductive wound dressing.

National Cmop Office (36C770)

POSTED

DEADLINE

AIR FORCE CRYPTOLOGIC OFFICE COMMERCIAL SOLUTIONS OPENING

Solicitation # FA7037-21-S-C001

The Air Force Cryptologic Office (AFCO) Cyberspace Intelligence Surveillance and Reconnaissance and Multi-Domain Innovation Division is soliciting innovative commercial capabilities through Commercial Solutions Opening FA7037-21-S-C001. The agency is seeking mature technologies and innovative services in Electromagnetic Warfare, Information Operations, and electromagnetic digital communications, with a specific goal of achieving a field demonstration within one year. The procurement process is divided into two phases: Phase I requires the submission of a quad chart and a white paper, while Phase II consists of full proposals by invitation only. Awards may be issued as traditional contracts or Other Transactions (OT), with potential funding ranging from 50,000 dollars to 50 million dollars over a period of performance lasting between one and five years. The evaluation process is based on technical merit, importance to agency programs, and fund availability, utilizing peer or scientific review to select offerors. Successful projects are expected to follow a structure of base period tasks to demonstrate feasibility, followed by option tasks for design, fabrication, testing, and evaluation. Because the work supports DoD ISR-Cyber capabilities, offerors must possess the necessary personnel and facility security clearances to handle classified work independently. All acquired technologies are treated as commercial items under 10 USC 3458 and DFARS 212.70. Submissions are managed by Carissa Heuertz, and the performance location is identified as San Antonio, Texas.

Department Of Defense

POSTED

DEADLINE

In-Vitro Diagnostics, Point of Care Testing & Pathology Services Project_1717

Solicitation # Project_1717

Supply Chain Coordination Limited, acting for NHS Supply Chain, is establishing an open national framework agreement for the provision of In-Vitro Diagnostic Devices, Point of Care Testing Products, and Related Pathology Services. The scope of the procurement is extensive, covering pathology managed services, reagent rental agreements, pathology software, and core laboratory equipment and consumables across multiple disciplines, including biochemistry, microbiology, immunology, cellular pathology, virology, haematology, genomics, molecular testing, and reproductive sciences. Additionally, the framework includes point of care testing and specimen collection and storage. The procurement is organized into three distinct lots: Pathology Managed Services, Pathology Software Solutions, and Diagnostics Testing Solutions. The estimated total value for the initial period is 703,101,796 GBP excluding VAT, with a potential total value of approximately 2,545,824,000 GBP excluding VAT over the full eight-year framework duration. The estimated contract period runs from October 18, 2027, to October 17, 2029, with an overall framework end date of October 17, 2035. Proposals must be submitted electronically by December 16, 2026. Evaluation for Lots 1 and 2 is weighted at 80 percent for non-financial quality, 10 percent for social value, and 10 percent for price. Lot 3 is evaluated based on 60 percent non-financial quality, 30 percent cost, and 10 percent social value.

Supply Chain Coordination Limited

POSTED

DEADLINE

in about 2 months

Pathology ServicesThis subcontract for Pathology Services involves providing diagnostic pathology support for prime contractors working on projects for the Kingston University Higher Education Corporation. The scope of work includes the collection of biological samples and the execution of laboratory analysis utilizing specialized diagnostic equipment and pathology software to deliver comprehensive test results and diagnostic reports. To ensure quality and compliance, the provider must hold recognized laboratory accreditation, such as ISO 15189 or equivalent UK standards. Interested parties must submit their responses by the deadline of November 27, 2026, as specified in the solicitation posted on October 28, 2026.

Kingston University Higher Education Corporation

POSTED

DEADLINE

REBID - IN HOUSE DRUG TESTING SERVICES FOR THE PORT AUTHORITY OF NEW YORK AND NEW JERSEY – FOUR (4) YEAR REQUIREMENTS CONTRACT

Solicitation # 2140325

The Port Authority of New York and New Jersey has issued solicitation number 6000003540 for a four year requirements contract to provide in house drug testing services. This procurement falls under NAICS code 621511 and NIGP codes 94874 for professional medical services and 19300 for clinical laboratory reagents and tests. The contract is designed to ensure the availability of drug monitoring and diagnostic testing services over a multi year period. Interested bidders must submit their proposals electronically via the Euna portal by the deadline of November 10, 2026. The Port Authority has ceased public bid openings, making electronic submission the only accepted method. In accordance with Title VI of the Civil Rights Act of 1964, the agency ensures full and fair opportunity for all businesses regardless of race, color, national origin, age, or disability. Procurement inquiries and submissions are managed by the Procurement Operations office located at 150 Greenwich Street, 21st Floor, New York, New York 10007.

The Port Authority of New York and New Jersey

POSTED

DEADLINE

REBID - FEDERAL DRUG TESTING SERVICES FOR THE PORT AUTHORITY OF NEW YORK AND NEW JERSEY – FOUR (4) YEAR REQUIREMENTS CONTRACT

Solicitation # 2140324

The Port Authority of New York and New Jersey is soliciting bids for solicitation number 6000003539, a four year requirements contract for federal drug testing services. This rebid covers professional medical services and clinical laboratory reagents and tests, specifically falling under NIGP codes 94874 and 19300. The contract will be performed state wide in New York. Bids must be submitted electronically via the Euna portal by November 10, 2026, at 11:00 AM, as the Port Authority has temporarily ceased public bid openings. All procurement activities are conducted in accordance with Title VI of the Civil Rights Act of 1964 to ensure full and fair opportunity without discrimination. For technical assistance or inquiries, the Procurement Operations Bid/RFP Custodian can be reached at [email hidden] or [phone hidden].

The Port Authority of New York and New Jersey

POSTED

DEADLINE